Trigen Completes Management Team
01 août 2002 04h25 HE
|
Trigen
LONDON, August 1, 2002 (PRIMEZONE) -- Trigen Ltd. today announced the appointment of Dr. Suresh Chahwala as VP Drug Discovery and Dr. Sophie Combe as VP Clinical Development. Both appointments bring...
Pharmexa Plans Clinical Trials in the U.S.A and Releases New Data from Its AutoVac HER-2 Protein Breast Cancer Product
21 mai 2002 06h41 HE
|
Pharmexa A/S
HARSHOLM, Denmark, May 21, 2002 (PRIMEZONE) -- Following a successful pre-IND meeting with the Food and Drug Administration (FDA) in the United States, Pharmexa has decided to conduct the first...
atugen Announces Functional Genomics Collaboration with Byk Gulden
14 mai 2002 02h44 HE
|
atugen AG
BERLIN, Germany, May 14, 2002 (PRIMEZONE) -- atugen AG today announced a three year, collaboration with Byk Gulden, the pharmaceutical group of ALTANA AG, to validate a number of novel genetic...
CeNeS Pre-clinical Candidate rhGGF2 Cited as Potential Treatment for Schizophrenia
14 mai 2002 02h37 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, U.K., May 14, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today noted recent press coverage on the identification of a risk gene for schizophrenia that has implications for its...
Astex Announces Appointment of Vice President of Biology
14 mai 2002 02h30 HE
|
Astex Therapeutics
CAMBRIDGE, U.K., May 14, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company pioneering the use of high throughput X-ray crystallography technology, today announced the...
Pyrosequencing Introduces SNP and Mutation Analysis System Dramatically Reducing Costs; Second Major Product Launch in 2002
15 avr. 2002 08h19 HE
|
Pyrosequencing
UPPSALA, Sweden, April 15, 2002 (PRIMEZONE) -- Pyrosequencing AB (Stockholm: PYRO A) today announced the worldwide launch of the PSQ(tm)HS 96A System - based on proven Pyrosequencing(tm) technology. ...
Precise Biometrics has Implemented a Directed Share Issue Worth SEK 30.5 Million
29 janv. 2002 08h35 HE
|
Precise Biometrics AB
LUND, Sweden, Jan. 29, 2002 (PRIMEZONE) -- Precise Biometrics has implemented a share issue worth SEK 30.5 million directed at Swedish investment institutions. The company is on the brink of a market...
CeNeS Signs AutoPatch Technology Agreement with Wyeth-Ayerst Research, a Division of American Home Products Corporation
14 nov. 2001 02h43 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, United Kingdom, Nov. 14, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) announced today that it had signed an agreement worth $1.2 million for the supply of its proprietary ion...
CeNeS Appoints Dan Welch to Board of Directors
04 sept. 2001 02h50 HE
|
Hugin Online
CAMBRIDGE, UK, Sept. 3, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN.L) today announced the appointment of Mr. Dan Welch to the Board as a non-executive director.
Dan Welch, currently...
Galapagos Genomics and Vertex Pharmaceuticals in Gene Function Collaboration (with link)
22 août 2001 08h39 HE
|
Hugin Online
LEIDEN, The Netherlands, Aug, 22, 2001 (PRIMEZONE) -- Galapagos Genomics NV, the Belgian functional genomics company, today announced a research collaboration with Vertex Pharmaceuticals...